BioCardia, Inc.
BCDA
$0.82
-$0.06-6.50%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.70% | 13.59% | 14.62% | -24.48% | -19.63% |
| Total Depreciation and Amortization | -75.00% | -80.00% | -75.00% | -70.59% | -36.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.59% | -31.54% | -33.09% | -25.10% | 8.99% |
| Change in Net Operating Assets | -54.11% | -44.46% | 67.82% | 266.67% | 75.39% |
| Cash from Operations | -2.53% | -2.63% | 35.96% | -25.69% | -5.75% |
| Capital Expenditure | -- | -500.00% | 100.00% | 66.67% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -500.00% | 100.00% | 66.67% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.13% | -87.18% | -5.77% | -8.33% | -85.54% |
| Repurchase of Common Stock | -- | -40.71% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -575.00% | -300.00% | 25.28% | 77.42% | 82.22% |
| Cash from Financing | -40.31% | -130.40% | -2.34% | -5.93% | -85.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.65% | -9.07% | 22.74% | -93.43% | -823.38% |